pSivida Corp. (NASDAQ:PSDV) shares fell 1.6% on Friday . The stock traded as low as $3.67 and last traded at $3.71, with a volume of 54,868 shares traded. The stock had previously closed at $3.77.

Separately, FBR & Co reiterated a “buy” rating on shares of pSivida Corp. in a research report on Wednesday, July 20th. One analyst has rated the stock with a sell rating, one has given a hold rating and three have assigned a buy rating to the stock. pSivida Corp. currently has an average rating of “Hold” and a consensus price target of $7.00.

The stock’s 50 day moving average price is $3.83 and its 200-day moving average price is $3.20. The stock’s market capitalization is $126.44 million.

pSivida Corp. is a biotechnology company, which is engaged in the development of sustained-release drug-delivery products for treating eye diseases. The Company offers products for treatment of back-of-the-eye diseases. The Company’s lead development product, Medidur is used for posterior of the eye (posterior uveitis).

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.